Yamamoto T, Tsukita Y, Katagiri Y, Matsushita H, et al. Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice. BMC Cancer 2022;22:364.
PMID: 35379201